-
公开(公告)号:US11732266B2
公开(公告)日:2023-08-22
申请号:US17080771
申请日:2020-10-26
Applicant: AMGEN INC.
Inventor: Michael Ollmann , Yang Li , Jun Zhang , Oliver Homann , Leslie P. Miranda , Justin K. Murray , Bin Wu , Oh Kyu Yoon , John Gordon Allen , Chawita Netirojjanakul , Yuan Cheng
IPC: C12N15/113 , A61P9/10 , A61P3/06 , C07K16/28
CPC classification number: C12N15/1138 , A61P3/06 , A61P9/10 , C07K16/2851 , C07K2317/526 , C12N2310/14 , C12N2310/315 , C12N2310/317 , C12N2310/321 , C12N2310/332 , C12N2310/351 , C12N2310/3513 , C12N2310/321 , C12N2310/3521 , C12N2310/322 , C12N2310/3533 , C12N2310/322 , C12N2310/3531
Abstract: The present invention relates to RNAi constructs for reducing expression of the ASGR1 gene. Methods of using such RNAi constructs to treat or prevent cardiovascular disease, such as coronary artery disease and myocardial infarction, and to reduce serum non-HDL cholesterol levels are also described.
-
公开(公告)号:US10344060B2
公开(公告)日:2019-07-09
申请号:US14773756
申请日:2014-03-12
Applicant: AMGEN INC.
Inventor: Justin K. Murray , Jerry Ryan Holder , Malgorzata Wanska , Christopher M. Tegley , James R. Falsey , Elizabeth M. Doherty , Leslie P. Miranda , Kaustav Biswas , Bin Wu , Kelvin Sham , Jason C. Long
IPC: C07K14/00 , C07K14/435 , C07K16/00 , C07K19/00 , C07K14/46 , C07K14/47 , A61K38/00 , A61K38/16 , A61K38/17 , A61K47/64 , A61K47/68
Abstract: Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted NaV1.7 inhibitor. In some disclosed embodiments, the isolated polypeptide is an inhibitor of NaV1.7. Other embodiments are conjugated embodiments of the inventive composition of matter and pharmaceutical compositions containing the inventive composition of matter. Isolated nucleic acids encoding some embodiments of inventive polypeptides and expression vectors, and recombinant host cells containing them are disclosed. A method of treating or preventing pain is also disclosed.
-
公开(公告)号:US09796766B2
公开(公告)日:2017-10-24
申请号:US15134305
申请日:2016-04-20
Applicant: AMGEN INC.
Inventor: Justin K. Murray , Leslie P. Miranda , Stefan I. McDonough
IPC: C07K14/435 , C07K14/00 , A61K47/48 , C07K16/44 , A61K38/00
CPC classification number: C07K14/43518 , A61K38/00 , A61K47/60 , A61K47/68 , A61K47/6817 , C07K14/00 , C07K16/44 , C07K2317/35 , C07K2317/76 , C07K2319/30
Abstract: Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted NaV1.7 inhibitor. In some disclosed embodiments, the isolated polypeptide is an inhibitor of NaV1.7 and/or NaV1.3. Other embodiments are conjugated embodiments of the inventive composition of matter and pharmaceutical compositions containing the inventive composition of matter. Isolated nucleic acids encoding some embodiments of inventive polypeptides and expression vectors, and recombinant host cells containing them are disclosed. A method of treating or preventing pain is also disclosed.
-
公开(公告)号:US09636418B2
公开(公告)日:2017-05-02
申请号:US14207445
申请日:2014-03-12
Applicant: AMGEN INC.
Inventor: Justin K. Murray , Jerry Ryan Holder , Malgorzata Wanska , Christopher M. Tegley , James R. Falsey , Elizabeth M. Doherty , Leslie P. Miranda
IPC: C07K14/435 , A61K47/48 , C07K16/44 , C07K14/705 , A61K38/00
CPC classification number: A61K47/48438 , A61K38/00 , A61K47/60 , A61K47/68 , A61K47/6817 , C07K14/43518 , C07K14/705 , C07K16/44
Abstract: Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted NaV1.7 inhibitor. In some disclosed embodiments, the isolated polypeptide is an inhibitor of NaV1.7. Other embodiments are conjugated embodiments of the inventive composition of matter and pharmaceutical compositions containing the inventive composition of matter. Isolated nucleic acids encoding some embodiments of inventive polypeptides and expression vectors, and recombinant host cells containing them are disclosed. A method of treating or preventing pain is also disclosed.
-
-
-